{
  "ptid_time": "036_S_6088_2017-10-12",
  "img_path": "/data/qiuhui/data/adni/images/036_S_6088/2017-10-12/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 17,271 mm³, 22.7% below the reference mean. With a Z-score of -0.57 (28.5th percentile), this represents normal volume ; hippocampal volume measures 6,673 mm³, 13.2% below the reference mean. With a Z-score of -1.48 (7.0th percentile), this represents mild atrophy; whole brain volume measures 888,554 mm³, 13.7% below the reference mean. With a Z-score of -1.70 (4.4th percentile), this represents moderate atrophy; entorhinal cortex volume measures 3,532 mm³, 9.3% below the reference mean. With a Z-score of -0.72 (23.6th percentile), this represents normal volume ; fusiform gyrus volume measures 18,557 mm³, 1.9% above the reference mean. With a Z-score of 0.21 (58.5th percentile), this represents normal volume ; middle temporal gyrus volume measures 14,708 mm³, 28.3% below the reference mean. With a Z-score of -2.52 (0.6th percentile), this represents significant atrophy. ",
  "text_data": "Age is 69.2 years. Gender is Female. Education: 18 years. Handedness: Right. Race: White. MMSE: 29.0. MoCA: 27.0. Logical Memory: 16.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.37 SUVR (significant elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows mild hippocampal atrophy (Z-score -1.48, 7th percentile) and moderate whole-brain atrophy (Z-score -1.70, 4.4th percentile), with significant atrophy in the middle temporal gyrus (Z-score -2.52, 0.6th percentile). Despite these findings, cognitive scores (MMSE 29, MoCA 27) remain in the normal range, suggesting preserved function despite structural changes. The presence of an APOE4 allele and elevated AV45 (amyloid PET) indicates amyloid pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amyloid-positive, early neurodegenerative changes)  \n**Confidence:** **Medium** (cognitive scores are normal, but imaging and biomarkers suggest early pathology; clinical correlation needed for progression monitoring).",
  "timestamp": "2025-07-26T06:21:48.813175"
}